Pharmaceuticals · Key players

Top IgA Nephropathy Treatment companies

The 5 key players our IgA Nephropathy Treatment report profiles, and other companies free public records show in this market.

Key players in IgA Nephropathy Treatment

In the order our report profiles them, not ranked by sales. Each name opens the company's page with its public records.

Key players in the IgA Nephropathy Treatment market
#CompanyWebsiteOur reports
1 Calliditas Therapeutics — 33 reports
2 Travere Therapeutics — 33 reports
3 Novartis AG novartis.com (opens in a new tab) 1,551 reports
4 Vera Therapeutics — 33 reports
5 Otsuka Pharmaceutical Co., Ltd. — 231 reports

Also active in IgA Nephropathy Treatment

Other companies that free public records show in this market: trials they lead, US approvals and WHO prequalification. They are not part of our key players research. Each count opens its source.

Also active in IgA Nephropathy Treatment, from free public records
CompanyWhere public records show them
AstraZeneca
Haisco Pharmaceutical Group Co., Ltd.
Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd.
Jade Biosciences, Inc.
Chengdu Suncadia Medicine Co., Ltd.
Biogen Inc
Triastek, lnc.
Keymed Biosciences Co.Ltd
ADARx Pharmaceuticals, Inc.
Biohaven

Source: ClinicalTrials.gov, Active studies (recruiting, about to start or running) each company leads, found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

Top trial sponsors in IgA Nephropathy Treatment

Companies leading the most active studies found with this market's trial search, worldwide (key players included).

  1. Novartis AG 12 active trials on ClinicalTrials.gov (opens in a new tab)
  2. Vera Therapeutics 3 active trials on ClinicalTrials.gov (opens in a new tab)
  3. Otsuka Holdings Co Ltd 3 active trials on ClinicalTrials.gov (opens in a new tab)
  4. AstraZeneca 2 active trials on ClinicalTrials.gov (opens in a new tab)
  5. Haisco Pharmaceutical Group Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  6. Travere Therapeutics 2 active trials on ClinicalTrials.gov (opens in a new tab)
  7. Rigerna Therapeutics Co., Ltd.; Rigerna Therapeutics (Beijing) Co., Ltd. 2 active trials on ClinicalTrials.gov (opens in a new tab)
  8. Jade Biosciences, Inc. 2 active trials on ClinicalTrials.gov (opens in a new tab)

Source: ClinicalTrials.gov, Industry lead sponsors of active studies found with this market's trial search, worldwide. Retrieved 13 Nov 2026.

IgA Nephropathy Treatment reports by place

All 33 places for IgA Nephropathy Treatment

Get the full IgA Nephropathy Treatment report

Company profiles, market shares and strategies come with the full report, with researched size, forecast, growth and segments.

Buy the full report Request free sample

Key players are our report's research. Other companies and trial counts come from free public records, each with its source. Acuitas market figures are not published on this page.